AVR - חובות לטווח קצר של החברה anteristech.com
The development of advanced heart valves is a high-tech competition with stringent barriers to entry, where any breakthroughs by competitors can prove fatal. Anteris Technologies Global (AVR) is expanding rapidly, offering the market the durable DurAVR transcatheter option made from seamless tissue. This price chart on the GURU.Markets platform reflects the asset's dynamics, while the separate_debt_short metric stands at 0.00.
פילוחים אנליטיים ודוחות נתונים של חברת Anteris (AVR)
In-house production of biomaterials minimizes supply chain risks for Anteris Technologies Global (AVR). Analyzing the current volume of short-term loans, an investor sees obligations maturing within twelve months. This metric aggregates all current loans and notes to assess the company's liquidity. An increase in this figure signals a potential shortage of working capital. A stable debt level confirms financial stability while scaling testing outsourcing.